Skip to main content
Clinical Trials/IRCT20200921048790N1
IRCT20200921048790N1RecruitingPhase 3

Comparison of the effect of probiotic vaginal with conventional treatment on delivery outcome and pro inflammatory cytokine levels in patients with premature rupture of fetal membranes

Sanandaj University of Medical Sciences0 sites108 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
108

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 40 years (—)
Sex
Female

Inclusion Criteria

  • Pregnant mothers 20 to 40 years old with P-PROM without risk factor

Exclusion Criteria

  • Body mass index equal to or greater than 29
  • Metabolic diseases
  • Uterine abnormalities,
  • Patients with cervical insufficiency
  • Pregnancy with assisted reproductive techniques

Investigators

Sponsor
Sanandaj University of Medical Sciences

Similar Trials